Biomedica
Tracked across 2 events · 12 articles · First seen Jul 13, 2026 · Last active Sep 15, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Business
Biomedica. issued a corrected press release on September 14, 2026, fixing the exchange ratio for its proposed merger with Zoar Limited. The original September 11, 2026 release incorrectly stated that Impact stockholders would receive one…
Impact: Impact Biomedical is the central entity, correcting its merger exchange ratio and approving a 1-for-12.62 reverse stock split to support its proposed combination with Zoar Limited and NYSE American listing objectives. The clarification reduces uncertainty but the stock remains speculative.
Sep 15, 2026 · 6 articles
Business
Impact: Biomedica gains exclusive distribution rights for AGAMREE in five additional countries, strengthening its rare disease portfolio in emerging markets.
Jul 13, 2026 · 6 articles
80
Biomedica approved reverse stock splitImpact Biomedical Zoar...
70
Biomedica corrected merger exchange ratio Zoar LimitedImpact Biomedical Zoar...
40
Biomedica approved reverse stock splitImpact Biomedical Zoar...
20
Equiniti Trust Company appointed transfer agent BiomedicaImpact Biomedical Zoar...
ERGEN INTELLIGENCE
Track Biomedica live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard